3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
442
Rectal Neoplasms
209
Colonic Neoplasms
202
Pancreatic Neoplasms
133
Stomach Neoplasms
117
Neoplasm Metastasis
86
Esophageal Neoplasms
57
Carcinoma, Hepatocellular
41
Adenocarcinoma Of Esophagus
37
Neoplasms
36
Cholangiocarcinoma
27
Biliary Tract Neoplasms
23
Gastrointestinal Neoplasms
20
Gallbladder Neoplasms
20
Adenocarcinoma
19
Carcinoma, Non-Small-Cell Lung
16
Esophageal Squamous Cell Carcinoma
15
Liver Neoplasms
14
Bile Duct Neoplasms
14
Digestive System Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Colorectal Cancer Metastatic
8
Appendiceal Neoplasms
7
Peritoneal Neoplasms
6
Ovarian Neoplasms
6
Intestinal Neoplasms
6
Carcinoma
6
Breast Neoplasms
6
Lung Neoplasms
5
Carcinoma, Renal Cell
5
Interventions
Blood Specimen Collection
4
Liquid Biopsy
2
trastuzumab deruxtecan
1
tislelizumab
1
fludarabine phosphate
1
fludarabine
1
Pirinitramide
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Morphine
1
Leucovorin
1
Irinotecan
1
HMPL-013
1
Folfox protocol
1
Fluorouracil
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Analgesia, Epidural
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Leucovorin
×
Gastrointestinal
×
Clear all
NCT05427669
2022-10-07
AFFORD
Sun Yat-sen University
Phase 3
Not yet recruiting
340 enrolled